Ditchcarbon
  • Contact
  1. Organizations
  2. Adaptive Biotechnologies
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 3 days ago

Adaptive Biotechnologies

Company website

Adaptive Biotechnologies Corporation, headquartered in the United States, is a pioneering leader in the biotechnology industry, specialising in immune-driven medicine. Founded in 2009, the company has made significant strides in harnessing the power of the adaptive immune system to develop innovative diagnostic and therapeutic solutions. With a focus on areas such as oncology and infectious diseases, Adaptive Biotechnologies offers unique products like the clonoSEQ® assay, which provides precise insights into the immune repertoire. This technology stands out for its ability to detect and quantify specific immune cells, enabling personalised treatment strategies. Recognised for its contributions to precision medicine, Adaptive Biotechnologies has established a strong market position, collaborating with major pharmaceutical companies and research institutions to advance the field of immunology.

DitchCarbon Score

How does Adaptive Biotechnologies's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Adaptive Biotechnologies's score of 25 is lower than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.

41%

Let us know if this data was useful to you

Adaptive Biotechnologies's reported carbon emissions

Adaptive Biotechnologies, headquartered in the United States, currently does not report any specific carbon emissions data, as indicated by the absence of figures in kg CO2e. However, the company is committed to climate action, having established near-term reduction targets as part of its sustainability initiatives. As of June 2025, Adaptive Biotechnologies is classified as "Committed" to near-term targets, although specific numerical goals or timelines have not been disclosed. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, which is increasingly focusing on reducing its environmental impact. While no emissions data is cascaded from a parent company, Adaptive Biotechnologies is actively engaging in climate commitments to enhance its sustainability profile. The absence of reported emissions highlights an opportunity for the company to further define its climate strategy and set measurable targets in alignment with industry standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Adaptive Biotechnologies's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Adaptive Biotechnologies is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Adaptive Biotechnologies is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Nanostring Technologies

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Inivata Limited

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Illumina

US
•
Research and development services (73)
Updated 2 days ago

C2I Genomics Inc.

US
•
Research and development services (73)
Updated 22 days ago

Foundation Medicine, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Fulgent Genetics

US
•
Other business services (74)
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy